If you know of a resource or opportunity that could be shared, please email it to amurdoch@cansolveckd.ca
CSN COVID-19 Rapid Response Team Recommendations
| Home dialysis recommendations |
| Management of acute kidney injury |
| Management of advanced chronic kidney disease |
COVID-19 Trials Listing
Below is a list of COVID-19 specific study websites and websites with study lists. As the number of COVID-19 related studies increases, we will do our best to keep this page updated.
Active Canadian trials listed on ClinicalTrials.gov can be found here.
| Study | Description |
| COVID-19 PEP RCT | Health care workers and those living with COVID-19 positive people in Alberta, Manitoba and Quebec are eligible to participate in a trial of post-exposure prophylaxis. Learn more |
| COVID-19 Core Outcomes Study | COVID-19-COS project brings together patients, the public and health professionals to identify, prioritise and agree on the most important outcomes for research in COVID-19. Round 1 is planned to close on April 10. Learn more |
| COVID-19 Resources Canada | COVID-19 Resources Canada lists ongoing Canadian trials that can be sorted by Principal Investigator, Institution or Research Category. Learn more |
Clinical Trial Management Resources
As the COVID-19 pandemic continues, most hospitals have halted all non-emergency visits, greatly affecting the conduct of clinical trials. Below are links to both Health Canada and the US Food and Drug Administration (FDA) guidance on the management of clinical trials during this time, as well as various Canadian research organizations. This post will be updated as more resources come to our attention.
We are working to collect a list of trial resources to help trialists overcome challenges and keep their research programs moving forward. If you have had success or suggestions that you can share, please email amurdoch@cansolveckd.ca.
COVID-19 Funding Opportunities
CIHR COVID-19 Rapid Research Funding Opportunity – CLOSED
Deadline for submission is May 11. Funding will support clinical trials, observational studies, implementation science or other relevant study designs to scale-up promising existing projects, reorient current research, or initiate new rapid response research to address COVID-19 in the identified research areas that include understanding the safety, efficacy, effectiveness, ethics, and implementation of:
- vaccines, diagnostics, or therapeutics;
- clinical management and health system interventions; and
- social, policy, and public health responses and related indirect consequences.
Visit their website, here, for more information.